Industry Ignited Podcast
Industry Ignited is a platform for bold conversations with leaders who are transforming the way business gets done. Each episode spotlights breakthrough stories from the industrial, manufacturing, biotech, chemical, and B2B sectors, giving you an inside look at how top executives, innovators, and changemakers tackle real-world challenges and drive meaningful growth.
Hosted by Dr. Leeanne Aguilar—entrepreneur, executive coach, and marketing strategist—Industry Ignited goes beyond surface-level discussions to uncover the strategies, mindsets, and lessons that fuel leadership at the highest level. From navigating complex operations and scaling companies to rethinking culture and preparing for the future of work, every conversation is designed to inspire, challenge, and equip you with fresh perspectives.
Whether you’re an executive, entrepreneur, or emerging leader, this podcast will spark ideas, expand your vision, and ignite the drive to lead with confidence in today’s evolving business landscape.
Industry Ignited Podcast
Cellular Zip Codes and Cancer Care: David Loynd on Endurex’s Breakthrough Delivery Platform | Ep. 12
In this episode of Industry Ignited, Dr. Leeanne Aguilar interviews David Loynd, President & CEO of Endurex Pharmaceuticals, on how a peptide-directed nanoparticle drug delivery platform—built around “cellular zip codes”—targets tumors while sparing healthy tissue. Drawing on engineering discipline, systems thinking, and partnerships with institutions like MD Anderson, David explains why traditional chemotherapy’s systemic toxicity falls short and how Endurex localizes payloads to hard-to-treat cancers such as triple-negative breast cancer, ovarian cancer, and glioblastoma. We dive into manufacturing-minded optimization (design of experiments, polymeric nanocarriers), scale-up paths (microfluidics, impinging-jet, or patient-specific small-scale units), and a pipeline that extends beyond chemo to immunotherapies, RNA/antisense cargos, and vaccine delivery. The result: potential for higher efficacy, lower toxicity, improved patient experience, and scalable systems that move from invention to impact. If you’re in biotech, pharma operations, or industrial process design, this conversation is a masterclass in precision delivery, process innovation, and commercialization strategy.